Basic Information
LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML
INFUSION, SOLUTION CONCENTRATE
Regulatory Information
SIN17002P
May 8, 2024
Prescription Only
Therapeutic
INTRAVENOUS
June 19, 2024
June 4, 2025
Company Information
ROCHE SINGAPORE PTE. LTD.
Active Ingredients
Mosunetuzumab
Strength: 30 mg/30 ml